Belgium started its COVID-19 vaccination programme on 28 December, following the European Commission’s approval of the Pfizer-BioNTech vaccine. Our first vaccines were sent out to a few rest homes all over the country.
Belgium as a pharmaceutical hub also contributes to the global fight against COVID-19 in developing and producing vaccines, drugs and medical products. The presence of the biggest pharma world leaders –such as Pfizer and GSK–, universities and research centres made it possible for Belgian companies and individuals to play a prominent role in the development of a vaccine. Our unique aerial, maritime and terrestrial logistic capabilities are up to the challenges of the distribution and transport of pharma products around the world.
International solidarity is key in fighting the epidemic. In the words of our Minister for Development Cooperation Meryame Kitir: “No country in the world will be safe from COVID-19 as long as not all countries are safe.”. Belgium hence allocated 4 million euros to the COVAX initiative to contribute to making the vaccine available in every country in the world, and will continue to play a pioneering role in this endeavour.